cangrelor
chemical compound
Facts
15 properties- Instance of
- type of chemical entity
- Subclass of
- chemical compound
- Has use
- medication
- Active ingredient in
- Kengrexal, Kengreal
- Canonical SMILES
- CSCCNC1=NC(=NC2=C1N=CN2C3C(C(C(O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O)SCCC(F)(F)F
- Chemical formula
- C₁₇H₂₅Cl₂F₃N₅O₁₂P₃S₂
- Defined daily dose
- 50 mg
- Isomeric SMILES
- CSCCNC1=NC(=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O)SCCC(F)(F)F
- LiverTox likelihood score
- LiverTox toxicity likelihood category E
- Mass
- 774.948313 Da
- Physically interacts with
- G protein-coupled receptor 17, Purinergic receptor P2Y12, Purinergic receptor P2Y13
- Pregnancy category
- US pregnancy category C
- Significant drug interaction
- nabumetone, naproxen, celecoxib, Diclofenac, piroxicam, meloxicam, (RS)-fenoprofen, (±)-flurbiprofen, ibuprofen, indomethacin, (RS)-ketoprofen, (RS)-etodolac
- Subject has role
- platelet aggregation inhibitors, purinergic P2Y receptor antagonists
- World Health Organisation international non-proprietary name
- cangrelor
🏷️ Also known as
en Kengreal®
en AR-C69931MX
en ARL69931
en cangrelor
en Cangrelor
en [dichloro-[[[(2R,3S,4R,5R)-3,4-dihydroxy-5-[6-(2-methylsulfanylethylamino)-2-(3,3,3-trifluoropropylsulfanyl)purin-9-yl]oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]methyl]phosphonic acid
ar كانجريلور
fa کانگرلور
it C17H25Cl2F3N5O12P3S2
pl kangrelor
ru кангрелор
🔖 Identifiers · 30
- OpenAlex ID
- C2776708134
- ATC code
- B01AC25
- CAS Registry Number
- 163706-06-7
- ChEBI ID
- 90841
- ChEMBL ID
- CHEMBL334966
- ChemSpider ID
- 8029718
- DSSTOX compound identifier
- DTXCID8090142
- DSSTox substance ID
- DTXSID90167651
- DrugBank ID
- DB06441
- DrugCentral ID
- 5006
- Freebase ID
- /m/064lcz8
- Guide to Pharmacology Ligand ID
- 1776
Show all 30 identifiers +18
- HSDB ID
- 8489
- Human Metabolome Database ID
- HMDB0240386
- InChIKey
- PAEBIVWUMLRPSK-IDTAVKCVSA-N
- KEGG ID
- D03359
- LiverTox ID
- Cangrelor
- MeSH descriptor ID
- C117446
- Microsoft Academic ID (discontinued)
- 2776708134
- NDF-RT ID
- N0000191733
- Probes And Drugs ID
- PD009299
- PubChem CID
- 9854012
- Reaxys registry number
- 8303713
- RxNorm CUI
- 1656052
- SureChEMBL ID
- 6113860
- UNII
- 6AQ1Y404U7
- UniChem compound ID
- 271131
- WikiProjectMed ID
- Cangrelor
🔗 Connections
Significant drug interaction 27
← Significant drug interaction 27
Has use 1
Subclass of 1
Subject has role 1
Press Enter · cited answer in seconds
0 sources
Summary
cangrelor is a type of chemical entity[1]. cangrelor is a type of chemical compound[2].
Key Facts
- Physically interacts with: G protein-coupled receptor 17[3], Purinergic receptor P2Y12[4], Purinergic receptor P2Y13[5]
- Canonical SMILES: CSCCNC1=NC(=NC2=C1N=CN2C3C(C(C(O3)COP(=O)(O)OP(=O)(C(P(=O)(O)O)(Cl)Cl)O)O)O)SCCC(F)(F)F[6]
- Chemical formula: C₁₇H₂₅Cl₂F₃N₅O₁₂P₃S₂[7]
- Has use: medication[8]
- Significant drug interaction: nabumetone[9], naproxen[10], celecoxib[11], Diclofenac[12], piroxicam[13], meloxicam[14], (RS)-fenoprofen[15], (±)-flurbiprofen[16], ibuprofen[17], indomethacin[18], (RS)-ketoprofen[19], (RS)-etodolac[20], sulindac[21], parecoxib[22]
- Isomeric SMILES: CSCCNC1=NC(=NC2=C1N=CN2[C@H]3C@@HO)SCCC(F)(F)FC@@HO)SCCC(F)(F)F">[23]
- Mass: 774.948313 dalton[24]
- World Health Organisation international non-proprietary name: cangrelor[25]
- Subject has role: platelet aggregation inhibitors[26], purinergic P2Y receptor antagonists[27]
- Pregnancy category: US pregnancy category C[28]
- Active ingredient in: Kengrexal[29], Kengreal[30]
- Defined daily dose: 50 milligram[31]
- LiverTox likelihood score: LiverTox toxicity likelihood category E[32]